Life Healthcare Group

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

for the year ended 30 September 2020

Download (EXCEL)

	2020  R'm		Change  %		2019  R'm
Cash generated from operations	4 562		(23.0)		5 927
Transaction costs paid relating to acquisitions and disposals	(17)				(147)
Finance income received	93				60
Tax paid	(597)				(1 185)
Net cash generated from operating activities	4 041		(13.2)		4 655
Capital expenditure	(1 964)				(2 060)
Investments (net of cash acquired) and contingent considerations paid	(43)				(269)
Proceeds from disposal of subsidiary and joint venture	–				4 395
Premiums paid/settlement of foreign exchange option contracts relating to disposal of joint venture	–				(322)
Other	13				27
Net cash (utilised in)/generated from investing activities	(1 994)				1 771
Proceeds from interest-bearing borrowings	12 766				5 996
Repayment of interest-bearing borrowings	(13 525)				(10 052)
Contingent considerations paid	(37)				–
Dividends paid to Company's shareholders	(778)				(1 321)
Finance costs paid	(823)				(984)
Other	(381)				(404)
Net cash utilised in financing activities	(2 778)				(6 765)
Net decrease in cash and cash equivalents	(731)				(339)
Cash and cash equivalents – beginning of the year	677				1 006
Effect of foreign currency rate movements	152				10
Cash and cash equivalents at end of the year1	98				677

1	Cash and cash equivalents at the end of the year are net of bank overdrafts.